SUrveilling Prospective Population cOhorts for COVID19 pRevalence and ouTcomes in Canada (SUPPORT-Canada)

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:2 publications

Grant number: 172762

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2020
  • Known Financial Commitments (USD)

    $1,579,114.5
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Abelson Sagi, Awadalla Philip, Bhatti Parveen, Cheung Angela Man-Wei, Dick John Edgar, Dummer Trevor James Benjamin, Lettre Guillaume, Mclaughlin John Ross, Simpson Jared Thomas, Sweeney Ellen, Turner Donna C Ranneris, Vena Jennifer Elizabeth, broet philippe
  • Research Location

    Canada
  • Lead Research Institution

    Ontario Institute for Cancer Research
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The ability to assess the spread and severity of the COVID-19 pandemic is central to our ability to inform a targeted and proportional public health response, both now and in the future. Here, we will leverage major prior investments into Canadian health platforms to enable the rapid development of a Canadian COVID-19 cohort and research resource that will enable the real-time assessment of population susceptibility and prevalence and act as a critical resource to support both population and clinical-level research at a national scale. The initiative titled SUrveilling Prospective Population cOhorts for COVID19 pRevalence and ouTcomes in Canada (SUPPORT-Canada) aims to capture data and biologics to enable population-level surveillance, and enable researchers and clinicians to find factors contributing to COVID-19 susceptibility and severity, thus identifying high risk individuals or communities across Canada. Building on partnerships between the Canadian Partnership for Tomorrow's Health, Canada's largest population cohort, the University Hospital Network, and regional partners, SUPPORT-Canada is a collaborative effort, with both national and global partners, that will and capture critical short- and long-term COVID-19 clinical features from affected and unaffected Canadians. Our platform has been designed to integrate with national and global research efforts to support clinical, immunological and genetic studies of COVID19. Our integrated approach will enable rapid data sharing and translation of findings to the public health and research community. The identification of diagnosed and symptomatic participants within the Canadian population will enable rapid surveillance that can support our public health agencies at the community and the individual level. Capturing COVID-19-specific information will enable us to provide the research community timely data to support surveillance, prevention and risk factor research.

Publicationslinked via Europe PMC

Last Updated:4 hours ago

View all publications at Europe PMC

Cohort Profile: The Ontario Health Study (OHS).

Storm Waves May Be the Source of Some "Tsunami" Coastal Boulder Deposits.